Commonwealth Equity Services’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Buy
31,060
+2,763
+10% +$733K 0.02% 730
2026
Q1
$3.1M Buy
28,297
+3,896
+16% +$555K ﹤0.01% 1674
2025
Q4
$4.06M Buy
24,401
+8,005
+49% +$1.34M 0.01% 1474
2025
Q3
$3.21M Sell
16,396
-7,441
-31% -$1.22M ﹤0.01% 1657
2025
Q2
$2.15M Buy
23,837
+14,492
+155% +$1.14M ﹤0.01% 1924
2025
Q1
$558K Sell
9,345
-3,439
-27% -$318K ﹤0.01% 2942
2024
Q4
$1.69M Buy
+12,784
New +$1.2M ﹤0.01% 1990

Other funds holding ALAB

Commonwealth Equity Services's ALAB Position: Q2 2026 in Review

Commonwealth Equity Services increased its Astera Labs (ALAB) stake by 9.8% in Q2 2026, buying an estimated $733K and bringing the position to 31,060 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #730.

Commonwealth Equity Services first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Commonwealth Equity Services held 31,060 shares of Astera Labs worth $15M as of Q2 2026.
  • Commonwealth Equity Services bought 2,763 Astera Labs shares in Q2 2026, an estimated $733K.
  • Astera Labs made up 0.02% of Commonwealth Equity Services's portfolio in Q2 2026, its #730 holding.
  • Commonwealth Equity Services first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.